These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10508482)
1. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. Sowter HM; Corps AN; Smith SK Int J Cancer; 1999 Nov; 83(4):476-80. PubMed ID: 10508482 [TBL] [Abstract][Full Text] [Related]
2. Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts. Baykal C; Demirtaş E; Al A; Ayhan A; Yüce K; Tulunay G; Köse MF; Ayhan A Int J Gynecol Cancer; 2004; 14(1):152-6. PubMed ID: 14764044 [TBL] [Abstract][Full Text] [Related]
3. Comparison of HGF (hepatocyte growth factor) levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts. Baykal C; Demirtas E; Al A; Ayhan A; Yuce K; Tulunay G; Kose MF; Ayhan A Int J Gynecol Cancer; 2003; 13(6):771-5. PubMed ID: 14675313 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Corps AN; Sowter HM; Smith SK Int J Cancer; 1997 Sep; 73(1):151-5. PubMed ID: 9334823 [TBL] [Abstract][Full Text] [Related]
5. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018 [TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells. Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787 [TBL] [Abstract][Full Text] [Related]
8. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer. Parrott JA; Skinner MK Biol Reprod; 2000 Mar; 62(3):491-500. PubMed ID: 10684788 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Klominek J; Baskin B; Liu Z; Hauzenberger D Int J Cancer; 1998 Apr; 76(2):240-9. PubMed ID: 9537587 [TBL] [Abstract][Full Text] [Related]
11. Differential processing of type I and type III procollagens in the tumour cysts and peritoneal ascitic fluid of patients with benign and malignant ovarian tumours. Zhu GG; Melkko J; Risteli J; Kauppila A; Risteli L Clin Chim Acta; 1994 Sep; 229(1-2):87-97. PubMed ID: 7988058 [TBL] [Abstract][Full Text] [Related]
12. Early inflammatory response in epithelial ovarian tumor cyst fluids. Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours. Wilson AP; Fox H; Scott IV; Lee H; Dent M; Golding PR Br J Cancer; 1991 Jan; 63(1):102-8. PubMed ID: 1989647 [TBL] [Abstract][Full Text] [Related]
14. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours. Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer. Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408 [TBL] [Abstract][Full Text] [Related]
16. [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance]. Zhang RT; Shi HR; Huang HL; Chen ZM; Liu HN; Yuan ZF Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1551-5. PubMed ID: 21945764 [TBL] [Abstract][Full Text] [Related]
17. Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. Wong AS; Roskelley CD; Pelech S; Miller D; Leung PC; Auersperg N Exp Cell Res; 2004 Sep; 299(1):248-56. PubMed ID: 15302591 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum. Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in adnexal masses. Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872 [TBL] [Abstract][Full Text] [Related]
20. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary. Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]